VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 40 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 40 | -43.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 71 | -42.3% | 0.00% | – |
| Q1 2022 | $1,000 | -90.9% | 123 | -82.5% | 0.00% | – |
| Q4 2021 | $11,000 | +266.7% | 704 | +252.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 200 | -60.0% | 0.00% | – |
| Q4 2020 | $6,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -33.3% | 500 | -10.6% | 0.00% | – |
| Q2 2020 | $6,000 | -14.3% | 559 | -16.3% | 0.00% | – |
| Q1 2020 | $7,000 | -36.4% | 668 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +57.1% | 668 | +24.9% | 0.00% | – |
| Q3 2019 | $7,000 | -12.5% | 535 | -6.1% | 0.00% | – |
| Q2 2019 | $8,000 | -52.9% | 570 | -39.4% | 0.00% | – |
| Q1 2019 | $17,000 | – | 940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |